Navigation Links
Indiana Biopharmaceutical Service Providers Maintain Steady Growth Despite Industry Challenges
Date:2/10/2010

INDIANAPOLIS, Feb. 10 /PRNewswire/ -- Indiana's contract pharmaceutical research and manufacturing companies continued to expand in 2009, despite challenges in the biopharmaceutical contract service sector due to the downturn in the economy, the prospect of healthcare reform and other market developments.  New service providers were established, facility expansions were announced, and service line extensions were added by companies such as AIT Laboratories, BioConvergence, BioStorage Technologies and Covance.

In an updated survey on biopharmaceutical market developments, Industry Developments in U.S. Biopharmaceutical Contract Services, BioCrossroads highlights evolving trends in the contract service sector, including the industry-wide drive for pharmaceutical and biotechnology companies to lower costs, access specialized services and increase flexibility through outsourcing work to contract service providers (CSPs). This new report supplements the major sector study prepared by BioCrossroads in 2008, Biopharma Discovery and Development Contract Services – Indiana Market Opportunities and Funding Options.

"We believe the outlook for the biopharma contract service sector continues to be positive, particularly for Indiana's pharmaceutical development and contract manufacturing companies," said David Johnson, president and CEO of BioCrossroads, Indiana's public-private collaboration for investment, development and advancement of the state's signature life sciences strengths. "The emergence of fully integrated pharmaceutical networks (FIPNETs) has changed the landscape and accelerated the pace of pharmaceutical product development. The trend of outsourcing that we predicted in our 2008 BioCrossroads study is now standard practice for bringing a product to market in this industry."

The new report acknowledges that while 2009 was slow for many CSPs, the underlying reasons for pharmaceutical and biotechnology companies to outsource selected activities will continue for the foreseeable future.  CSPs should continue to grow as the pharmaceutical industry moves towards a more flexible business model. Biomarker services and the need for larger clinical trials will provide opportunities for additional growth in future years.   However, with the consolidation of the pharmaceutical industry and the continued trend of strategic partnerships between CSPs and their clients, many companies in the sector will be drawn to find new revenue sources.  

"Outsourcing to contract organizations helps reduce the high costs and long lead times of product development while minimizing scientific and business risks," said Alisa Wright, president and CEO of Bloomington, IN-based BioConvergence. "Because of the growing needs for specific development functions that our pharmaceutical clients requested, we added service lines in 2009, including collection kit production and  biorepository capacity.  We plan to expand our services further in 2010."

With nearly 9,000 workers and more than 40 companies working in the CSP sector, Indiana is a national center for biopharma development and manufacturing.  The state is one of only a few regions in the United States with a concentration of companies that excel in specialized and sophisticated drug development services such as contract research, contract manufacturing, and logistics.  BioCrossroadsLINX was established in 2007 to develop and strengthen these Indiana drug development and manufacturing capabilities through educational and workforce development programs and regional collaborations.

The full report is available at www.biocrossroads.com and www.biocrossroadslinx.com

About BioCrossroads

BioCrossroads (www.biocrossroads.com) is Indiana's initiative to grow, advance and invest in the life sciences, a public-private collaboration that supports the region's existing research and corporate strengths while encouraging new business development.  BioCrossroads provides money and support to life sciences businesses, launches new life sciences enterprises (Indiana Health Information Exchange, Fairbanks Institute for Healthy Communities, BioCrossroadsLINX, and Datalys Center), expands collaboration and partnerships among Indiana's life science institutions, promotes science education and markets Indiana's life sciences industry. 

SOURCE BioCrossroads

RELATED LINKS
http://www.biocrossroads.com

'/>"/>

SOURCE BioCrossroads
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Indiana Industry, University and Community Leaders Capitalize on Next Generation of States Life Sciences Growth
2. Collaboration of Indianas Health Information Exchanges, State Organizations Submits Application for Health Information Technology Stimulus Funding
3. A New Economic Future for Rural Indiana?: Study to Show How Renewable Energy Could Trigger Boom for Economically Struggling Areas in State
4. Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition
5. Expanding Indianas Breakthroughs in Health Information Technology (Exibhit Indiana): Initiative to Advance the States Health IT National Leadership and Assets Launched to Bring More Awareness to Sector
6. Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation
7. Hoosiers Work for Health Highlights Impact of Medical Research and Innovation on Indiana Economy
8. Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex
9. Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the Worlds Largest, Most-Advanced Automated Pharmacy
10. SynCo Bio Partners Signs New Manufacturing Agreements to Supply the US Market; Securing its Position as a Market Leader in Microbial Biopharmaceutical Contract Production
11. ClearTrial to Demonstrate Dramatic Gains in Clinical Outsourcing Efficiency Achieved by Biopharmaceutical Companies at European Outsourcing Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Sequenom, Inc. (NASDAQ: ... enabling healthier lives through the development of innovative products ... the United States denied its ... the claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 ... criteria established by the Supreme Court,s Mayo Collaborative Services ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, ... faculty of the University of North Carolina Kenan-Flagler Business School effective ... at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of ... their brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been ... Target to its list of well-respected retailers. This list includes such fine stores ...
Breaking Biology Technology:
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
Breaking Biology News(10 mins):